Pyrazinamide
Back to searchMolecule Structure
Scientific Name
Pyrazinamide
Description of the Drug
Pyrazinamide is an antituberculosis agent used as a component of tuberculosis (TB) treatment.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00339
http://www.drugbank.ca/drugs/DB00339
Brand Name(s)
Pirilene, Pyrafat, Pyrazinamide, Tebrazid
Company Owner(s)
Macleods Pharmaceuticals Ltd, Sanofi Aventis Us Llc, Novitium Pharma Llc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363965 |
| Fatty acid synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL2011 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24102 | |
| PharmGKB | PA451182 | |
| Human Metabolome Database | HMDB0014483 | |
| DrugBank | DB00339 | |
| PubChem: Thomson Pharma | 15119868 | |
| PubChem | 1046 | |
| Mcule | MCULE-6846697749 | |
| NMRShiftDB | 20050094 | |
| LINCS | LSM-5425 | |
| Nikkaji | J3.990J | |
| PDBe | PZA | |
| BindingDB | 228814 | |
| EPA CompTox Dashboard | DTXSID9021215 | |
| DrugCentral | 2328 | |
| Brenda | 101385 | 3666 |
| Rhea | 45285 | |
| ChemicalBook | CB7429387 | |
| Guide to Pharmacology | 7287 | |
| rxnorm | PYRAZINAMIDE | |
| PubChem: Drugs of the Future | 92309395 | |
| KEGG Ligand | C01956 | |
| ChEBI | 45285 | |
| ZINC | ZINC000000002005 |
